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Abstract
Sepsis, a life-threatening condition caused by infection, is a leading cause of mortality
and morbidity globally. Researchers suggest that early identification of sepsis upon
admission to the emergency department (ED) can help mitigate the consequences of
sepsis. The emergency department of a hospital in a large urban U.S. city has participated
in the Centers for Medicare & Medicaid Services’ sepsis reporting system (SEP-1) since
2015; however, recent reports indicated below benchmark scores. As more than half of
patients diagnosed with sepsis were admitted or readmitted through the ED, the purpose
of this project was to develop a clinical practice guideline, informed by Rosswurm and
Larrabee’s evidence-based practice model and a literature search, for use in the ED with
input from an expert advisory panel using the AGREE II tool criteria across six domains.
A 4-member panel member, comprised of the ED’s medical director, director of nursing,
nurse manager, and an ED staff nurse unanimously recommended the use of the
guideline. Domain scores ranged from 40 to 100%, with a mean of 83%. This sepsis
clinical guideline scored highest in the domains of scope and purpose (100%) and clarity
and presentation (95%) and applicability (83%). The domains of stakeholder involvement
(40%) and editorial independence (57%) had the lowest domain scores. The overall
quality assessment score was 7 based on a Likert scale ranging from 1 (lowest possible
quality) to 7 (highest possible quality). In making sepsis screening a routine practice
informed by a clinical guideline, nurses at the project site may be able to identify sepsis
earlier in patients presenting to the ED, resulting in improved outcomes, promoting a
positive social change, and increasing the SEP-1 scores.
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Section 1: Nature of the Project
Introduction
Sepsis is a life-threatening condition caused by infection and represents a
substantial global health burden. As a leading cause of mortality and morbidity, sepsis is
responsible for more than five million patients dying yearly around the world (Centers for
Disease Control and Prevention [CDC], 2016). The CDC (2016) noted that one in every
three patients in the United States who die in the hospital dies from sepsis with most
patients presenting with symptoms of infection on arrival at the hospital. Among those
patients who are discharged after being treated for sepsis, 40% are readmitted to the
hospital within 3 months with more than 70% of those readmitted having physical and
cognitive functional decline (Al Khalaf et al., 2015; Iwashyna et al., 2010).
Early identification of sepsis and interventions are key elements in preventing this
decline as well as preventing increased length of stay and mortality in this population.
Both early identification and timely and appropriate interventions have been reported to
decrease mortality and improve patient outcomes (Kim & Park, 2019). Nurses are in a
unique position to identify the early signs of sepsis in patients presenting to the
emergency department (ED) as they complete an initial assessment upon the patient’s
entry to the ED. Equipped with a clinical guideline on early identification, nurses may be
able to ensure timely recognition of patients showing signs of sepsis that will prompt
evidence-based interventions to diagnose and treat this condition.

2
Problem Statement
This project was based on the premise that use of an early identification sepsis
clinical guideline by nurses in an ED located in a large urban center can improve sepsis
management, reduce its burden, and support adherence to the Sepsis National Hospital
Inpatient Quality Measure [SEP-1] (Dellinger, et al., 2004) quality measure. The Centers
for Medicare & Medicaid Services (CMS) developed SEP-1 to address the need for
timely delivery of high-quality sepsis care in U.S. hospitals. Officials use the SEP-1 as a
quality indicator to measure a hospital’s adherence to standards in comparison with other
hospitals. Adherence to CMS quality measures is vital as hospitals risk losing
accreditation with poor compliance.
The Doctor of Nursing Practice (DNP) project site--the ED of a hospital in a large
urban U.S. city--provided an opportunity for improvement in the early identification of
sepsis in the adult patient population, as more than half of patients diagnosed with sepsis
are admitted or readmitted through the ED. Although the project site has participated in
the SEP-1 reporting system since 2015, recent reports indicate scores that are below
benchmark. In making sepsis screening a routine practice informed by a clinical
guideline, ED nurses may be able to maximize outcomes for this population and
increase the SEP-1 scores.
Purpose
The purpose of this project was to develop a clinical practice guideline (CPG)
with input from an expert panel. The practice-focused question was: Can a
multidisciplinary group develop evidence-based CPGs that meet the AGREE II criteria
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for the screening and early identification of sepsis in patients presenting to the ED?
Screening can lead to expedited delivery of care to patients with sepsis. Sepsis
guidelines dictate that patients should receive antibiotics within 3 hours of admission to
the institution making early identification crucial to quality outcomes. However, the
patient must first be identified as having sepsis (Klienpell & Schorr, 2016).
Nature of the Doctoral Project
The purpose of this project was to develop a CPG with input from an expert
panel. I developed a CPG on screening and early identification of patients for sepsis who
present to an urban ED. The purpose of a CPG is to narrow the gap between an
organization's current practice and delivery of optimal care (Graham et al., 2011; Holly,
et al. 2021). The gap that exists is lack of early identification of sepsis in the adult
population presenting to the project ED resulting in the SEP-1 reports as below
benchmark. By following a guideline for early screening and early identification, nursing
staff may be able to diagnose and treat sepsis in a timelier manner.
Sources of evidence used in this project included a literature review to support
developing a clinical guideline on the early identification of sepsis in the ED using
Medline/PubMed, Cumulative Index to Nursing and Allied Health Literature (CINAHL),
and the Cochrane Library. I constructed a table of evidence. The latest recommendations
from the Surviving Sepsis Campaign were integrated into the guideline. Following
completion of the guideline, an expert panel assessed the guideline using the AGREE II
tool (Brouwers, et al., 2010).
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Significance
Sepsis is the 11th leading cause of death in the United States and the 10th for
those 65 years of age or older (Hayden et al, 2016; Rhodes et al., 2016). Between 2008
and 2011, combined Medicare and Medicaid inpatient reimbursements for sepsis totaled
$17.7 billion, 5% of which was for hospital stays classified as high-cost outliers (Torio &
Andrews, 2013). Reported in-hospital death rates vary by severity, ranging from 11% for
sepsis to more than 40% for septic shock (Gajeski et al., 2013). Early identification in the
ED to support focused interventions is essential for treating most life-threatening
diseases, including myocardial infarction, stroke, and cardiac arrest (Kleinpell, 2017).
However, compared with identification of these conditions, early identification of sepsis
is more complex as early signs are more subtle. The Surviving Sepsis Campaign
recommends the use of sepsis screening, which has been shown to reduce treatment time
and improve outcomes (Rhodes et al., 2016). Screening, for the purposes of this project,
was supported by the development of a sepsis clinical guideline for early identification of
sepsis in adult patients admitted to the ED. Stakeholders in this project were patients who
presented to the project site’s ED, ED nurses, and ED leadership. Moran et al. (2017)
stated that support and participation by stakeholders will increase stakeholders' awareness
and commitment to the process thus increasing the project’s credibility. Improvement in
the hospital SEP-1 benchmark will denote excellence in the care of the sepsis patient,
demonstrate that the organization is committed to maintaining a high standard of clinical
care, potentially provide the project site with a competitive edge in reimbursement, and,
last, reflect an improvement in patient outcomes.
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Summary
Sepsis is a severe health condition associated with a high mortality rate. Positive
patient outcomes are associated with the early identification and treatment of this
condition (Baison et al., 2019). More than a third of patients presenting with sepsis
symptoms are admitted through the project site ED making the area vital in lowering
patient mortality. Early goal-directed therapy (EGDT) for sepsis is dependent on the
timely recognition of the patient with sepsis. Nurses, as the largest bedside healthcare
provider, play a key role in ongoing monitoring of a patient’s condition. As such, nurses
should be on the forefront directing the screening process.
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Section 2: Background and Context
Introduction
The purpose of this project is to develop a CPG with input from an expert panel to
address the practice problem of lack of early identification of patients presenting to an
urban ED with signs suspicious of sepsis. The question I sought to answer in the project
was: Can a multidisciplinary group develop evidence-based CPGs that meet the AGREE
II criteria for the screening and early identification of sepsis in patients presenting to the
ED?
Sepsis is a clinical syndrome that triggers physiologic, biologic, and biochemical
abnormalities. It is a multifaceted response to infection and results in organ dysfunction,
which is attributed to insufficient tissue perfusion and oxygen delivery (Keep,2015).
Sepsis often begins when there is an infection in the body, whether bacterial, viral,
fungal, or parasitic. Potential sources of infection include the lungs, abdomen, urinary
tract, skin, intestines, brain, and bone, which are the most common venues for sepsis
((Keep,2015)).
Sepsis symptoms include shaking, chills, fever, weakness, rapid heart rate, rapid
breathing, low blood pressure, decreased urine output, nausea, vomiting, and diarrhea.
(Keep, 2015). The earliest indication of sepsis is the presence of temperature, less than
36°C (96.8 F) or greater than 38.3°C (100.9 F) (Keep,2015). Other commonly seen vital
signs associated with sepsis include a heart rate greater than 90 beats per minute and/or
respiratory rate greater than 20 breaths per minute (Keep,2015). Any of these signs
should prompt the triage nurse to suspect sepsis, thus triggering an emergency response
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(Keep et al, 2015). However, the hallmark of diagnosing sepsis is obtaining a blood
culture to identify the causative organism, so that the proper antibiotic is provided.
Sepsis is a life-threatening condition that if not treated early in its onset has a high
mortality rate and poor patient outcome (Keeley et al., 2017, Levy et al, 2020; Thompson
et al., 2019). Patients presenting to hospital with diagnosis of sepsis require prompt and
aggressive management to prevent complications and to improve outcomes as sepsis is a
leading cause of morbidity and mortality (Baison et al., 2019). The World Health
Organization (2019) identified sepsis as a global health crisis affecting more than 49
million individuals and resulting in more than 11 million deaths yearly.
Clinical Practice Guidelines
CPGs are statements that are systematically developed from a critical analysis of
the literature about a clinical question to assist practitioners in making appropriate
decisions regarding providing health care for specific clinical situations or conditions
(Graham et al., 2011). Guidelines promote high-quality, evidence-based health care and
decrease or reduce inappropriate variations in practice. The goal of a CPG is to optimize
patient care and improve patient outcomes (Emergency Nurses Association, 2015, The
National Academies of Science Engineering and Medicine: Health and Medicine
Division, 2018).).
The purpose of CPGs is to narrow the gap between an organization's current
practice and optimal care. CPGs guidelines can be a reference for clinicians, providing
information and supporting materials such as methodology, scientific evidence, and a
comprehensive bibliography (Holly et al., 2021). Guidelines focus on specific clinical
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circumstances, which may sometimes include clinically relevant organizational factors,
community characteristics, social variables, and similar influences on health care
delivery.
CPGs have a range of purposes and are intended to improve effectiveness and
quality of care, decrease clinical practice variations, and decrease costly and preventable
mistakes and adverse events (Agbassi, 2014). They usually include expected practice
statements; provide benchmarks or standards against which individuals can audit,
compare, and potentially improve their practices; or offer guidance regarding undertaking
tasks (Agbassi, 2014). The clarity of the guidelines determines a CPG’s effectiveness and
whether it is appropriate for the individual condition (Agbassi, 2014). CPGs can improve
processes and patient outcomes; however, their effectiveness is determined by the
organizational structures that support or undermine evidence-based practice and
successful implementation. CPGs must be well developed, be based on current scientific
evidence, and be user-friendly to be readily adopted (Busse et al., 2019). CPGs require
periodic revision and reviewing to guarantee that the recommended guidelines are current
and valid (Agbassi, 2014).
In 2004, the Surviving Sepsis Campaign recommended early goal-directed
therapy (EGDT) to manage severe sepsis and septic shock to decrease sepsis mortality by
25% over the following 5 years globally. Campaign officials developed the international
guidelines in response to the deadly effects of sepsis and to find means to improve the
morbidity and mortality rate (Dellinger et al., 2012). The Surviving Sepsis Campaign
guidelines were developed in 2004 and revised in 2008, 2012, and 2015. The aims of the
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guidelines for sepsis diagnosis and management were to reduce the mortality rate,
improve patients’ outcomes, and ensure a more reliable and timely application of
evidence-based care and standardized clinical practice with evidence-based bundles
(Dellinger et al., 2015). A bundle is a set of interventions that, when implemented
together, result in better outcomes than when implemented separately. The recommended
3-hour bundle requires that a blood culture be obtained before administration of any
antibiotic, that blood for lactate levels be sent to the laboratory for analysis, that broad
spectrum antibiotics be administered, and that 30 mL/kg of crystalloid fluid for
hypotension mean arterial pressure (MAP) < 65 or lactate > 4 be administered as
necessary (Dellinger et al. 2017).
The upgraded 2017 bundle recommendation is treatment within the first hour
known as time zero or time of presentation at triage in the ED or at the earliest time of
known assessment for sepsis symptoms in other clinical areas (Dellinger et al., 2017).
Clinicians can adapt and use the evidence-based guidelines recommended by the
Surviving Sepsis Campaign to impact patient outcomes and improve patient mortality
rates. Many researchers have adapted the Surviving Sepsis Campaign guidelines using
different strategies to change practices and improve sepsis outcomes in emergency and
inpatient units.
Romero et al. (2017) sought to establish the impact of implementing the sepsis
guidelines on triage assessment, ED management, and time to antibiotics. The
investigators conducted the study in a metropolitan Australian tertiary referral ED serving
a population of 70,000 annually. The Australian New South Wales government had
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identified that the recognition, assessment, and management of sepsis was a significant
challenge for ED clinicians. The recommendation was the standardization of sepsis
management of patients presenting with sepsis by emergency clinicians and triage nurses.
The sample included 157 patients pre- and postintervention. The intervention strategy
included an educational component for ED clinicians. The investigators selected a
randomized sample of medical records of presepsis guidelines over 12 months and the
same for postintervention patients (12 months). They audited records by comparing the
pre- and posteffect and identified that the sepsis guideline created a significant change in
the clinicians' management of sepsis patients. The time to antibiotics was within 60
minutes and significantly improved in the post sepsis guideline group. The time for the
pre- and post-group for patients to be seen by a nurse or doctor after triage was 39
minutes before guideline implementation. This decreased to 20 minutes after
implementation. There was also a 758 minute (12.6 hours) mean reduction in time to the
second liter of intravenous fluids (IVF) when comparing the pre- and post-group.
As well, Oliver (2018) conducted a retrospective chart review in a rural hospital
in Arkansas in a 33-bed ED treating over 70,000 patients yearly. Oliver measured if
implementing a sepsis assessment tool can increase the early recognition of a sepsis
patient and increase blood culture collection before antibiotic administration, and
decrease door to diagnosis times, presentation time to serum lactate measurement, and
diagnosis to antibiotic times. The investigator concluded that a screening tool could
improve the quality of care for sepsis patients and suggested that the assessment tool be
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embedded in the electronic medical record triage process as it would benefit the nurses
and promote compliance.
Gyang and colleagues (2015) conducted a pilot study to determine if using a
screening tool for sepsis as part of the nursing assessment may identify early sepsis in an
inpatient unit. Nurses involved in the pilot study had extensive education on sepsis and
related information before the pilot study. Clinical data were retrospectively analyzed
over 1 month. The medical team evaluated those patients who screened positive for sepsis
or severe sepsis and recorded their interventions. They screened 245 patients (169
surgical patients, 76 medical patients). Thirty-nine patients screened positive; 51% were
positive for sepsis, and 49% screened positive for severe sepsis. The screening tool
sensitivity and specificity were 95% and 92%, respectively. The test accuracy was 92%.
No statistically significant difference was noted.
Rusconi et al. (2015). conducted a systematic review and meta-analysis to assess
the effectiveness of EGDT versus usual care in the treatment of septic shock in those 18
years of age or older with a sepsis diagnosis. Rusconi et al. based their study on River et
al.'s (2006) landmark review stating that EGDT can reduce mortality with severe sepsis
and septic shock. Clinical studies were identified by searching the MEDLINE, EMBASE
databases and the Cochrane Central Register of Controlled Clinical Trials. The purpose
was to identify randomized controlled trials assessing the effectiveness of EGDT for
sepsis. The data from five studies, enrolling 4,033 patients, were included in the metaanalysis and analyzed using a random-effects model. The electronic search yielded 3,551
citations: 1,115 references in MEDLINE and 2,436 in EMBASE. Six hundred forty-nine
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references were duplicated between the two databases. Of a total of 2,902 references,
only 17 were relevant to the title and abstract screening. Due to variability across the
studies, the reviewers did not have a definitive conclusion about the effectiveness of
EGDT on severe sepsis and septic shock. Although Rosconi et al did not agree about the
EGDT effectiveness, Jirajariyave et al (2018) stated that sepsis is a serious disease with
high mortality and implied that early hemodynamic resuscitation after diagnosis with
severe sepsis or septic shock can led to lower organ dysfunction together with lower inhospital mortality rates.
Rhodes et al. (2017 evaluated the recommendations using the Surviving Sepsis
Campaign guidelines. The researchers formed a consensus committee of 55 international
experts from 25 international organizations grouped to evaluate Surviving Sepsis
Campaign Guidelines for sepsis. The consensus committee was then further divided into
subgroups. The committee used the principles of the Grading of Recommendations
Assessment, Development, and Evaluation (GRADE) methodology in assessing the
quality of evidence from high to low and to formulate recommendations as strong or
weak or best practice statements (related to hemodynamics, infection, adjunctive
therapies, metabolic, and ventilation). The Surviving Sepsis Guideline panel evaluated 93
reports on early management and resuscitation of sepsis or septic shock patients. Of the
results, 32 were strong recommendations, 39 were weak recommendations, and 18 were
best-practice statements.
In conclusion, even though early sepsis intervention is critically important to
patient survival, compliance in the clinical setting remains low. In institutions, the
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primary issue is identifying sepsis early in a patient, making early recognition one of the
most crucial aspects in sepsis care. Furthermore, clinicians need to know the importance
of time for sepsis patients and understand their roles in the patient's outcome. All
clinicians must understand the urgency and importance of time associated with sepsis
management.The Surviving Sepsis Campaign's guidelines can provide on-hand resources
to clinicians to help identify and manage sepsis treatment promptly. However, many
institutions do not have a detailed clinical guideline based on the campaign’s
recommendations to assist nursing clinicians in using real-time resources. Evidencebased clinical guidelines are tools that guide a clinician’s practice (Holly et all, 2021).
CPGs have the potential to reduce practice variations and improve the translation of
research into practice. A guideline based on scientific evidence can improve patient
outcomes by optimizing the process of care. A clinical guideline for the project institution
may help nursing clinicians in their decision-making to reduce delays from first medical
contact to appropriate therapy and avoid systemic errors when facing a suspected sepsis
case.
Concepts, Models, and Theories
I used Rosswurm and Larrabee’s (1999) evidence-based practice model as the
foundation for this project. The model describes a process for guiding nurses to integrate
evidence into their practices. The model has six stages: (a) assess the need for a practice
change; (b) link the problem, interventions, and outcomes; (c) synthesize best evidence;
(d) design the practice change; (e) implement/evaluate the change; and (f)
integrate/maintain the change.
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Step 1. Assess the Need for Change in Practice: Major steps in this phase are
identification of stakeholders, collection of internal data about current
practice, comparison of internal and external data to confirm the need for a
practice change, identification of the practice problem, and linking the
problem interventions and outcomes (Larrabee, 2009). The DNP project site
demonstrated an opportunity for improvement in the early identification of
sepsis in the adult population presenting to the ED as more than half of
patients diagnosed with sepsis are admitted or readmitted through the ED.
Although the project site has participated in the SEP-1 reporting system since
2015, recent reports indicate below benchmark scores (Larrabee, 2009).
Step 2. Locate the Best Evidence: Major steps in this phase are identifying the
best available evidence upon which to build the CPG. For this project, I
developed keywords and inclusion and exclusion criteria to guide a search
using Medline/PubMed, CINAHL, and the Cochrane Database of Systematic
Reviews available in the Walden University Library (Larrabee, 2009).
Step 3. Critically Analyze the Evidence: Major steps in this phase are critically
appraising and weighing the strength of the evidence; synthesizing the best
evidence; and assessing the feasibility, benefits, and risks of the new practice.
I determined levels of evidence and GRADE recommendations during this
step (Larrabee, 2009).
Step 4. Design Practice Change: Major steps in this phase are defining the
proposed practice change and identifying the needed resources. In this phase, I
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used the relevant articles found in searching the library and recommendations
of the Surviving Sepsis Campaign to develop the CPG for early sepsis
identification (Larrabee, 2009).
Although this project did not include implementation, this model can continue
to be used by stakeholders in the future for implementation purposes
following the development of the guideline.
Step 5. Implement and Evaluate Change in Practice: Major steps in this phase are
implementing a pilot study; evaluating the processes, outcome, and costs; and
developing conclusions and recommendations (Larrabee, 2009).
Step 6. Integrate and Maintain Change in Practice: Major steps in this phase are
communicating recommended change to stakeholders, integrating the new
practice into standards of practice, monitoring the process and outcomes
indicators, and celebrating and disseminating the results of the project
(Larrabee, 2009).
Relevance to Nursing Practice
Nurses are the largest provider of care in the ED and usually the first contact for
patients arriving in the department, usually at the triage process, making their role crucial
in the early recognition of sepsis symptoms. The patient sepsis outcome depends on early
recognition as delayed management can create a negative outcome. The key to early
identification is the nurse who first encounters the patient and suspects sepsis and
initiates an alert to the clinical team. Registered nurses are responsible for assessing
patients using the nursing process. As the role of the assessor of a patient, the registered

16
nurse is vital to the outcome of patients diagnosed with sepsis. Seventy percent of
patients are admitted through the ED making it the most appropriate area for using
guidelines for early recognition and management of septic patients (Al Khalaf et al.,
2015; Iwashyna et al., 2010).
The American Nurses Association (2015) supports nursing interventions utilizing
evidence from research studies to improve patient outcomes. Evidence-based practice is
the process of gathering, processing, and incorporating research findings to improve
clinical practice, the work environment, or patient outcomes. The utilization of evidencebased practice in nursing practice supports the provision of the highest quality of patient
care thus the evidence-based sepsis guidelines should be applied to patients presenting to
an institution with suspected sepsis symptoms. Sepsis can be difficult to identify as other
conditions present with the same signs and symptoms; nurses must be aware of the
Surviving Sepsis Campaign evidence-based guidelines strategies to identify and manage
sepsis. Providing resources that alert practicing clinicians to diagnosis can aid in making
informed decisions to identify sepsis. Sepsis is a time-dependent emergency that requires
prompt, effective interventions that focused on reducing the interval between a suspected
sepsis diagnosis and the effective evidence-based practice management that can improve
the patient outcome.
Early recognition of sepsis can be a challenge. Where barriers to improving
sepsis care exist, nursing education that teaches adherence to a policy or guideline has the
potential of impacting sepsis outcome. Identifying and addressing barriers to sepsis
recognition is vital in optimizing patients’ outcomes. Implementation of a CPG can
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provide the needed resources and empower clinical nurses to impact patient outcomes.
Advanced practice nurses such as DNP students/scholars can actively contribute and lead
positive patient outcomes by using evidence based, sustainable, context-sensitive
solutions. through ongoing evaluation and research in expanding body of knowledge as
well as actively participating in health policy agenda in all levels (Bateson & Patton,
2015).
Local Background and Context
The setting for this doctoral project was a 530-bed not-for-profit urban teaching
hospital in a large Northeastern U.S. city that provides a wide range of services including
medical-surgical, thoracic, cardiac, neurological, and pediatric services. It is a Level 2
Trauma Center with an ED with more than 100,000 visits yearly. The project site is
designated as a critical access hospital, where individuals who are acutely ill are seen in
large numbers due to the closure of many nearby healthcare facilities.
To improve quality care and reimbursement, the hospital began to participate in
the CMS core-bundle SEP-1 in October 2015. However, the hospital sepsis care had
fallen below the benchmark each year since participating in SEP-1. In the last few years
according to state report on Hospital Quality Performance on Sepsis Care Improvement
Initiative, the project institution was reported in the category of lowest performer in the
3- hour bundle and worst performer in the 6-hour bundle, such that the project institution
was below the 50th percentile in the 3-hour bundle and below the 20th percentile in the 6hour bundle (see Appendix A). The performance on these sepsis measures makes the
project institution an ideal place for utilizing a CPG. The ED admits approximately 70%
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of patients diagnosed with sepsis, making it the most appropriate area for a sepsis
guideline to be initiated.
Role of the DNP Student
The DNP Essentials refers to the student's education by outlining the curriculum
and competencies needed before conferring a DNP degree. Eight skills are the initial
outcome competencies deemed essential for all graduates of a DNP regardless of
specialty. The DNP graduate is prepared to use the knowledge gained from ethics,
biophysical, psychosocial analytical, and organizational sciences, incorporating it into
nursing science to provide the optimal nursing practice. The graduate used advanced
strategies to enhance, alleviate, and improve health and health care delivery using
scientific theories to develop and evaluate new practice approaches. The Doctor of Nurse
Practice Essential II: Organizational and Systems Leadership for Quality Improvement
states that the graduate role should contribute to nursing science by evaluating,
translating, and research into practice (American Association of Colleges of Nursing
(2006).
The DNP student's role in the project is to review and analyze evidence-based
research to develop and inform the CPG development and to lead the project team in the
assessment of the sepsis guideline using the AGREE II tool. As a DNP student, using the
knowledge I gained from Walden University and the experience as an ED nurse to assess,
I analyzed gaps in nursing practices, analyzed and reviewed evidence-based research,
translated it into nursing practices in the form of an CPG with the intent to improve
processes and patient outcomes for those patients presenting to the ED with sepsis.
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Role of the Project Team
The project team was a multidisciplinary group from the ED at the project site.
The team consisted of the ED medical director, ED nursing director of the nursing, ED
nurse manager, and ED staff nurse. The chairman and nursing director facilitated the
DNP student's access to the sepsis information and mentored the student throughout the
project. The project team reviewed the clinical guidelines and assessed it using the
AGREE II tool to aid in the eventual recommendation of the guideline.
Summary
In this section, I described the uses and current research on the use of clinical
guidelines for early sepsis identification. Rosswurm and Larrabee’s (1999) model guided the
project as it is a change theory that guides a systematic approach to developing and
integrating an evidence-based practice change. Four stages of the model were used. Stages
five and six can be used to implement, disseminate, and maintain the guideline, but were not
used in this project. Using this model assisted in the use of a systematic process develop a

CPG
The ED is the most used port of entry for sepsis patients, making it an ideal area to
start a sepsis management CPG. Providing a resource guideline is ideal and necessary for
nurses as the largest provider of care. They are usually the first contact with patients arriving
in the department, typically at the triage stage, making their role crucial in the early
recognition of sepsis symptoms.
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Section 3: Collection and Analysis of Evidence
Introduction
CPGs support the uptake of evidence into practice. They are developed to
provide healthcare practitioners with up-to-date information to make evidence-informed
decisions about health care and interventions for specific clinical conditions at the point
of care (Holly, et al. 2020). In this project, I developed a CPG using the Walden
University Manual on Development of Clinical Guidelines and the following four steps in
guideline development based on Rosswurm and Larrabee’s (1999) evidence-based
practice model:
1. Identifying and refining the target area
2. Assessing evidence identified by systematic literature review.
3. Translating evidence into recommendations.
4. Subjecting the guideline to stakeholder review.
Practice-Focused Question
The guiding question for this project was: Can a multidisciplinary group develop
evidence-based CPGs that meet the AGREE II criteria for the screening and early
identification of sepsis in patients presenting to the ED? This guideline and its subsequent
use may improve adherence to the SEP-1 quality measures and improve the early
identification and management of sepsis in the ED.
Sources of Evidence
I reviewed the literature to identify evidence to support developing a clinical
guideline on the early identification of sepsis in the ED. Sources for this search included
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Medline/PubMed, CINAHL, and the Cochrane Library. The search parameters were from
2004 to the present as 2004 was the initial publication of the Surviving Sepsis Campaign
recommendations. Keywords and phrases used were sepsis, sepsis guidelines, early
identification, screening, and sepsis outcomes. The guideline is evidence based in that the
latest recommendations from the Surviving Sepsis Campaign and literature review were
integrated. The use of guidelines increases adherence, according to researchers; Camp et
al. (2014) noted, for instance, that using a clinical guideline to confirm understanding of
discharge instructions, home care plans, and follow-up care promoted compliance to
home regimens.
Analysis and Synthesis
Synthesis
Appendix B presents the articles and other evidence I used in developing the
guideline for the project. Synthesizing the articles involved concisely summarizing and
linking different sources in a literature review on the topic and connecting the findings to
the guideline elements to be evidence-based. Instead of describing each article
individually, the integration of each source's main points resulted in overall evidencebased conclusions. This involved looking for similarities and differences among evidence
sources (Holly et al., 2020). I determined the level of evidence for each source using the
Agency for Healthcare Research and Quality (AHRQ) guidelines for determining levels
of evidence. The levels of evidence and GRADE recommendation of each source were
assigned based on the quality of their design, validity, and applicability to patient care
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(see Hendrickson et al. 2005). Using evidence levels enabled the expert panel to
determine how much confidence to put into findings.
Analysis
After developing the guideline, I gave it to an expert panel that included the ED
leadership (the director of nursing, director of medicine, nurse manager, and an ED staff
nurse) who assessed, evaluated, and determined their agreement using the 23-item
AGREE II instrument developed by Brouwers of McMaster University. This tool offers
a consistent and effective way to evaluate clinical guidelines (AGREE Research Trust,
2018). The instrument's two primary focus areas are overall guideline quality and
recommendation for use. Hoffmann-Eber et al. (2018) investigated the AGREE II
instrument's strength via a survey and found a robust assessment of guideline quality
and recommended it for use. Although the AGREE II instrument can be time-consuming
in comparison to other tools available, it is superior and the gold standard for clinical
guideline appraisal because of its focus on quality and application of a guideline
(Hoffmann-Eber et al. (2018).
This was a minimal risk, non-human subject project, and no patient information
was required for its completion. I obtained approvals to conduct the project from
Walden University’s Institutional Review Board and the project site.
Summary
Sepsis is a condition associated with a high mortality rate and poor patient
outcomes. Research has shown that EGDR for sepsis can positively impact patient
outcomes if there is timely recognition and management of the patient with sepsis.
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Multiple studies have confirmed that recognition and prompt treatment of sepsis, EGDT,
and the use of protocols improve patient outcomes (Chen et al. 2020; Chiweshe &
Ekelund, 2018; Ferguson et al. 2019; Hayden et al., 2016; Kleinpell,2017; Mattison et al.,
2016). Guidelines that integrate evidence-based research findings and meet the AGREE
II criteria for the screening and early identification of sepsis in patients presenting to the
ED may help alleviate sepsis patients' morbidity and mortality by providing on-time
resources to clinicians.
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Section 4: Findings and Recommendations
Introduction
This DNP project was concerned with sepsis, a medical emergency in which
outcomes depend on early recognition and rapid institution of resuscitative measures.
Sepsis triggers physiologic, biologic, and biochemical abnormalities that are a
multifaceted response to infection and results in organ dysfunction attributed to
insufficient tissue perfusion and oxygen delivery. The local problem was a lack of early
identification and treatment for patients presenting to an urban ED with signs of sepsis
resulting in poor performance on the SEP-1 standards for sepsis. The gap in practice was
lack of an evidence-based guideline to assist in early recognition. The purpose of this
project was to develop that guideline following the Walden DNP Manual for Clinical
Practice Guidelines. I conducted a literature search using PubMed, the CINAHL,
Nursing & Allied Health Database (ProQuest), and the Cochrane Library. Search terms
included in various combinations were sepsis, sepsis management in the ED, sepsis
research, sepsis protocols, and sepsis guidelines. Studies were selected using the
following criteria: original research, peer-reviewed, published in English, and with 5-year
timeframe for date of publication. Each article was reviewed to determine relevance to
the clinical question. I found 12 full-text articles that met the inclusion criteria and
informed the development of the CPG and placed these in a table of evidence (see
Appendix B). An expert panel reviewed the guideline against the AGREE II Tool to
appraise the quality of the developed guideline.
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Findings and Implications
I found 12 articles that supported the development of the guideline. The articles
were all peer reviewed and published between 2014 and 2019. Of these, one was Level I
evidence (Rusconi et al., 2015); three were Level III evidence (Gyang et al., 2015;
Romero et al., 2017; Trosvik et al., 2016); six were Level IV evidence (Freund et al.,
2017; Hayden et al., 2016; Leisman et al., 2019; Mattison, et al., 2016; Oliver, 2018;
Potocka et al., 2014), and two were Level V evidence (Nishida et al., 2018; Rhodes et al.,
2017). As presented in Appendix B:
•

eight of the studies were conducted in the United States

•

one study each was conducted in Norway, Japan, England, and Australia

•

seven studies took place in an ED

•

one study took place on an oncology unit

•

one study took place in an intermediate care unit

•

two studies were consensus statements

•

one study was a systematic review

The included studies were limited primarily using a single site in one hospital and
the use of data from medical record reviews. As I discuss, I categorized each of the
included studies by their level of evidence. Each study’s evidence was graded using the
GRADE system (see Table 2).
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Table 1
AHRQ Levels of Evidence
Level of evidence

Description

Level I

Meta-analysis of multiple studies

Level II

Experimental studies

Level III

Well-designed quasi-experimental studies

Level IV

Well-designed non-experimental studies

Level V

Case reports, clinical examples

Table 2
AHRQ GRADE Recommendation
GRADE

Recommendation

A

Strongly, recommend. Good evidence

B

Recommend. At least fair evidence

C

No recommendation for or against
Balance of benefits and harms too close to
justify a recommendation

D

Recommend against; Fair evidence is
ineffective, or harm outweighs the benefit

E

Evidence is insufficient to recommend for
or against routinely; Evidence is lacking
or of poor quality; Benefits and harms
cannot be determined.
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Level I Evidence
Level I evidence is signified by a systematic review and meta-analysis according
to the AHRQ Levels of Evidence (see Table 1). One study met this criterion (Rusconi et
al., 2015). The researchers conducted a systematic review and meta-analysis to compare
the effectiveness of EGDT to usual care in patients 18 years of age or older with
suspected sepsis diagnosis. MEDLINE and EMBASE databases and the Cochrane
Central Register of Controlled Clinical Trials were searched for studies that met their
inclusion criteria. The authors concluded that most of the reviewed studies showed
EGDT to be effective in the treatment of sepsis and recommended using EGDT until
further evidence is available. According to the AHRQ Grade schema (see Table 2), the
use of EGDT in the treatment of severe sepsis and septic shock would be considered
GRADE A (Strongly recommend; Good evidence). Consequently, it is reasonable to
consider EGDT in the care of patients with severe sepsis and septic shock.
Level II Evidence
There was no Level II evidence
Level III Evidence
Level III evidence is signified by a well-designed quasi-experimental study
according to the AHRQ Levels of Evidence (see Table 1). Three studies met this
criterion. Torsvik et al. (2016) conducted a non-randomized pre-post intervention study
to investigate whether implementing a clinical tool for triage of systematic inflammatory
response syndrome (SIRS), which included an organ failure alert prompt, treatment flow
chart along with reinforced training to improve clinical observations. After analyzing 900
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patients, Torsvik et al. realized that an increase in 30-day survival, less deterioration of
sepsis patients to severe sepsis, and shorter length of stay in the ICU in the
postintervention group could occur with the use of the clinical tool. According to the
AHRQ GRADE recommendations (see Table 2), this would be GRADE A evidence
(Strongly recommend; Good evidence).
Romero et al. (2017) sought to establish the effect of sepsis guidelines on triage
assessment, ED management, and time to antibiotics pre-and postimplementation of a
sepsis guideline in a metropolitan institution ED serving 70,000 annually in New South
Wales Australia. A new sepsis guideline was introduced into the ED to improve sepsis
recognition, assessment, and management. Data were collected included patient
demographics, clinical information (time of arrival, triage code, seen by time, disposition,
time to antibiotic, pathology, time to intravenous fluids), and patient assessment data
(heart rate, respiratory rate, blood pressure, temperature, oxygen saturation, medication).
Romero et al. concluded that the sepsis guidelines improved the early assessment,
recognition, and management of patients presenting with sepsis in the ED. The study
established a statistically significant 230-minute reduction in time to antibiotics
postimplementation of the guidelines. This study is GRADE A evidence (Strongly
recommend, good evidence)
Gyang and colleagues (2015) conducted an analysis to determine if using a
screening tool as part of the nursing assessment could identify early sepsis on an inpatient
unit. The assessments were conducted every 8 hours by nursing staff. A total of 2,143
screening tests were completed for 245 patients (169 surgical, 76 medical). ICD-9 codes
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confirmed that the sepsis incidence was 9%. Of the 39 patients who screened positive,
51% were positive for sepsis, and 49% screened positive for severe sepsis. The primary
team evaluated and provided intervention for patients screened positive for sepsis or
severe sepsis and recorded management of interventions. The authors determined that a
screening tool as part of a nursing assessment can identify early sepsis in medical and
surgical patients. This is a GRADE B study (Recommend, at least fair evidence).
Level IV Evidence
Six of the included studies were Level IV evidence (Freund et al., 2017; Hayden
et al., 2016; Leisman et al., 2019; Mattison et al., 2016; Oliver, 2018; Potocka, et al.,
2014) meaning that the evidence was generated from well-designed nonexperimental
study. Patocka et al. (2015) utilized a triage screening tool in a retrospective chart review
to detect septic patients presenting to the ED and determine the effect on time to
antibiotics in patients with suspected severe sepsis or septic shock. The reviewers
examined the time interval to antibiotics pre-and post-implementation of the triage tool.
Patocka et al. concluded that a screening tool could decrease antibiotics in patients
suspected of sepsis or septic shock. This study has Grade B evidence (Recommend; At
least fair evidence).
Mattison et al. (2016) investigated the use of a nurse-led protocol on time to
antibiotic administration in patients with neutropenia in an oncology department in
Northwest England. A chart review was performed 1 year after nurses were responsible
for assessing patients presenting with fever post-chemotherapy, including prescribing and
administering the first dose of intravenous antibiotics. The investigators concluded that
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there was a significant improvement in the time to antibiotic postintervention and
recommended that nurse-led protocols are safe and effective. This study is GRADE B
(Recommend, at least fair evidence).
Hayden et al. (2016) conducted a retrospective chart review to evaluate the
effectiveness of early, rapid identification of sepsis during ED triage. The investigators
hypothesized that a sepsis workup and treatment (SWAT) protocol that included rapid
mobilization of resources, standardized order sets, and early broad-spectrum antibiotics
and fluid resuscitation can reduce the time-to-intravenous fluids and time-to-antibiotics.
The investigators collected pre-and postinterventional patient medical records to
determine if a triage alert system and sepsis protocol can reduce door-to-antibiotics time,
door-to-intravenous (IVF) bolus time, and overall mortality. The researchers found a
reduction in the time-to-intravenous fluids and time-to-antibiotics in patients with
suspected sepsis, severe sepsis, or septic shock after implementing an EHR-based triage
sepsis alert using the SWAT protocol. This is GRADE B evidence (Recommend, at least
fair evidence).
Freund et al. (2017) conducted an international prospective cohort study using a
retrospective data base with 879 patients with suspected infection treated in an ED. Freud
et al. used screening tools, a quick Sequential Organ Failure Assessment (qSOFA) tool,
and SIRS criteria to predict patients' inhouse mortality following admission through the
ED. The researchers compared the qSOFA and the SIRs criteria to determine which can
better predict admission to the ICU, a stay longer than 72 hours in the ICU, and/or sepsis
related mortality from sepsis. The researchers concluded that the use of qSOFA resulted
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in greater prognostic accuracy for in-hospital mortality than did either SIRS or severe
sepsis to identify patients at high risk of mortality. This is a GRADE B study
(Recommend, at least fair evidence).
Oliver et al. (2018) conducted a retrospective chart review in a rural hospital in
Arkansas with a 33-bed ED treating over 70,000 patients yearly. The researchers
concluded that implementing a sepsis assessment tool can increase a sepsis patient's early
recognition; decrease door-to-diagnosis times, presentation time to serum lactate
measurement, and diagnosis to antibiotic times; and increase blood culture collection
before antibiotic administration. This is GRADE B evidence (Recommend, at least fair
evidence)
Leisman et al. (2019) conducted a comparative study to (a) measure and compare
the prevalence, characteristics, process, and patient outcomes of hospital-presenting
sepsis (HPS) patients versus ED-presenting sepsis (EDPS) patients and (b) estimate risk
differences in patient outcomes initial resuscitation disparities. The researchers used a
retrospective analysis of the Northwell Sepsis Database of all severe sepsis and septic
shock patients treated at a large hospital system in New York. The authors concluded that
HPS patients had more complex presentations than the EDPS group, received timely
antibiotics half as often as EDPS patients, and had twice the mortality odds. This is a
GRADE E study as it is only a descriptive study and no recommendations were made
(Evidence is insufficient to recommend for or against routinely; Evidence is lacking or of
poor quality; Benefits and harms cannot be determined).
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Level V Evidence
Rhodes et al. (2017) used an expert panel to assess the quality of 2012 Surviving
Sepsis Campaign guidelines. The expert panel researched and evaluated hemodynamics,
infection, adjunctive therapies, metabolic, and ventilation. Questions on population,
intervention, comparison, and outcomes (PICO) were reviewed and updated as needed.
Each group developed clinical questions to search for and assess the quality of available
evidence using the GRADE system. The expert panel developed a total of 93 statements
on early management and resuscitation of patients with sepsis or septic shock with 32
strong recommendations, 39 weak recommendations, and 18 best-practice
statements. This is GRADE B evidence (Recommend, at least fair evidence).
Nishida et al. (2018) also convened an expert panel in Japan to develop contextspecific CPGs for the care of sepsis patients. A total of 87 clinical questions were
selected among 19 clinical areas, including pediatrics. A meta-analysis was conducted for
29 of the clinical questions resulting in 37 recommendations in the form of an expert
consensus due to insufficient evidence from the meta-analysis. No recommendations
were provided for five clinical questions. This is GRADE E evidence (Evidence is
insufficient to recommend for or against routinely; Evidence is lacking or of poor quality;
Benefits and harms cannot be determined).
Implications
Sepsis is a medical emergency with a substantial mortality rate; however, many
studies have shown that early identification and rapid resuscitative measures can improve
patient outcomes and decrease the mortality rate (Dellinger et al. 2017; Oliver et al.,
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2018, Torsviket al., 2016). The 12 studies that I reviewed informed the development of
the CPG for the project site. I categorized the studies based on their Level of Evidence
(see Appendix B). Of the 12 studies, seven were done in an ED using screening tools,
protocols, and clinical guidelines to improve the early recognition of sepsis. The authors
of two studies (Nishida et al., 2016; Rhodes et al., 2017) used an expert panel to assess
and improve the quality of previous guidelines, focusing on early management. Most of
the researchers who used a screening tool or protocol found an improvement in reducing
time-to-intravenous fluids and time-to-antibiotics in patients with suspected sepsis and
improving recognition of sepsis. The implications for nursing practice include being able
to identify sepsis in all patients; patients might not present with sepsis at triage but while
awaiting a bed hence the inclusion of the three studies. The inclusion purpose is that
nurses must identify sepsis in all patients, whether at triage or while awaiting inpatient
beds.
Recommendations
Sepsis is a complex disease with a high mortality rate; therefore, the management
of sepsis evidence-based guidelines are needed to decrease mortality adequately. Even
though early sepsis intervention is critically important to patient survival, compliance in
the clinical setting remains low. One primary issue is identifying sepsis early in a patient,
as early recognition is crucial to sepsis outcomes. Sepsis treatment is time-sensitive
research studies have recommended the early initiation of therapy for patient survival and
quality of life. Furthermore, clinicians need to know the importance of time for sepsis
patients and understand their roles in outcomes. All clinicians must understand the
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urgency and importance of time associated with sepsis management. Identifying sepsis in
ED is a challenge as it can mimic other conditions; therefore, recommended protocolized
management can assist clinicians in early identification and management. Recognizing
these challenges, ongoing education, reinforcement of evidence-based guidelines can
assist in early and optimal resuscitation.
The institution’s problem relating to sepsis is the lack of early identification of
patients presenting in the ED with sepsis-associated symptoms. The initiation of a CPG
on sepsis management may reduce ineffective practices, reduce morbidity and mortality,
and improve the patient’s quality of life. The CPG is focused on three main areas:
screening and recognition of sepsis, early assessment and management, and reevaluation
of the patient during care.
CMS sepsis guidelines recommend early sepsis care that includes early
identification, and initiation of diagnostic testing and intervention. The proposed
development of this guideline and its subsequent use can improve adherence to the SEP-1
quality measures and improve early identification and management of sepsis in an urban
ED with a documented need for improvement in these areas. The purpose of this
guideline is to
propose criteria for early recognition of the signs and symptoms of sepsis,
severe sepsis, or septic shock
provide guidance in the timely implementation of evidence-based diagnostic
interventions, treatment, and other therapies
reduce delays in initiating therapy and improve patient outcomes
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narrow the gap between the organization’s current practice and optimal
evidence-based practice care
increase SEP-1 scores
This CPG is focused on the adult patient, 18 years and older, presenting to the ED
with confirmed or suspected sepsis or septic shock in a densely urban ED in a large
Northeast city in the United States. I developed this CPG based on a critical analysis of
the literature. The guideline is applicable to healthcare providers caring for adult sepsis
patients in the ED.
Definitions
Sepsis: A clinical syndrome that triggers physiologic, biologic, and biochemical
abnormalities. It is a multifaceted response to infection and results in organ dysfunction,
which is attributed to insufficient tissue perfusion and oxygen delivery (Singer, 2016).
Septic shock: A subset of sepsis in which particularly profound circulatory,
cellular, and metabolic abnormalities substantially increase mortality (Seymour et al.,
2016). Septic shock is associated with hypotension and perfusion abnormalities despite
the provision of adequate fluid (volume) resuscitation. Perfusion abnormalities include
lactic acidosis, oliguria, or an acute alteration in mental status (Singer, 2016).
Systemic inflammatory response syndrome (SIRS): A systemic response of the
body to a harmful stressor such as infection, trauma, surgery, inflammation, ischemia, or
malignancy (Singer, 2016).
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Guideline Recommendations
The initiation of the following guidelines is expected to reduce delays in
identifying and managing sepsis in the following areas:
1. Early identification.
2. Referral to appropriate provider.
3. Rapid vascular access for laboratory testing and intravenous infusion.
4. Empiric antibiotic therapy.
5. Titrated fluid resuscitation.
6. Early initiation of inotropes.
1. Screening and Recognition of Sepsis in New Patients. All patients 18 years
and older will be screened for sepsis by the triage nurse using the SIRS criteria. When
two or more SIRs criteria are identified the nurse must initiate a SEPSIS CODE. The
criteria for assessment are
temperature below 36 or above 38 degrees Celsius
systolic blood pressure (SBP) ≤ 90 mm Hg
heart rate greater than 90 breaths per minute
respiratory rate above 20 breaths per minute
Rationale. Sepsis is a medical emergency in which outcomes depend on early
recognition and rapid institution of resuscitative measures. Studies on early screening
show that rapid intervention helps to decrease mortality in septic patients (Hayden et al.,
2016; Gatewood et al., 2015). Rhodes et al. (2016), Kim and Park (2019), and Morr, et al.
(2016) stressed the importance of routine screening of potentially infected patients who
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are likely to be septic to improve the early identification and treatment of sepsis. They
highlighted the triage nurse’s role in the ED as crucial in the early recognition of sepsis
symptoms because these nurses are usually the first contact for patients arriving in the
department.
Standard: 100%. The triage nurse will use the SIRS criteria for screening every
patient over the age of 18 years who presents to the ED.
2. Specific Assessment. All patients must have their vital signs taken, recorded,
and evaluated by a Registered Nurse. The importance of temperature, heart rate,
respiration and blood pressure monitoring are essential to identify patients with
abnormality relating to sepsis. Ongoing evaluation of admitted patients can identify
patients at risk for sepsis or septic shock.
Rationale. Clinical evidence indicates that patients with acute deterioration or
sepsis manifest clinical signs or symptoms several hours before the condition worsens
(Roney et al, 2015). Thus, early identification, rapid initiation of antibiotics, and
adequate fluid resuscitation can lead to improvement in outcomes (Hayden, 2016).
Standard: 100%. The triage nurse will use the document temperature, heart rate,
respirations, and blood pressure for every patient over the age of 18 years who presents to
the ED.
3: Intervention. When a patient presents with two or more of the SIRS criteria,
the nurse will commence the following immediate actions:
initiate a SEPSIS CODE
place the patient in an ED room or equivalent treatment area
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address any compromise in airway and breathing
attach cardiac and monitoring and oxygen saturation monitoring
Within 10-15 minutes, the following actions need to be taken:
The medical provider must evaluate the patient.
The team must establish vascular access. If necessary, use intraosseous
needle (IO) for difficult vascular access.
Blood specimens must be obtained for include complete blood counts (CBC)
with differential, chemistries, serum lactate levels, liver function tests, lactate
levels, blood culture, blood gas, coagulation studies, type, and crossmatch
(optional), and urinalysis. (At a minimum lactate, blood culture, CBC,
Chemistries, urinalysis)
Initiate intravenous fluids resuscitation following the guidelines below.
Within 3 hours, the nurse must repeat serum lactate levels.
Rationale. The blood culture is the most important test in the management of
sepsis, and the clinical significance of identifying the pathogenic microorganisms causing
bacteremia. A blood culture should be taken prior to antimicrobial administration in
patients with sepsis or septic shock. The results will provide the source of infection
necessary for the diagnosis of sepsis or septic shock. The patient’s presenting signs and
symptoms, medical history, physical examination, and laboratory results will determine
the severity of the sepsis.
Standard: 100%. The triage nurse and medical provider will adhere to all
immediate, 15 minute, and 3-hour criteria.
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4. Empiric Antibiotic Therapy. Administer broad-spectrum antibiotics within
one hour of identification after obtaining blood cultures.
Rationale. Identification of the site of infection is vital to target antibiotic therapy.
The five possible sites causing sepsis are: 1) intra-abdominal infection, 2) infectious
pancreatic necrosis, 3) vascular catheter-associated infection, 4) urethral sources, and 5)
necrotizing soft tissue infection. Empiric antibiotics should be selected based on the
patient’s background, organs suspected to be affected, epidemiological information, and
recent use of antibiotics. The patient’s allergy history must be obtained before antibiotic
administration. According to the results of several studies, hourly delays in antibiotic
administration can increase the odds of hospital mortality (Lui et al., 2017; Corl et al.,
2020, Singer, 2017, Whiles, Deis, & Simpson, 2017). The recommendation is to
administer broad-spectrum antibiotics within one hour of identification and after
obtaining blood cultures.
Standard: 100%. Broad-spectrum antibiotics will be administered within one
hour of identification and after obtaining blood cultures.
5: Titrated Fluid Resuscitation. Initiating an access line is important in
obtaining labs, providing medications, and replacing loss fluid in patients with sepsis or
sepsis shock. The initial fluid administration is a bolus of 30 ml/kg crystalloid for
hypotension or a serum lactate of > 4 mmol/L within an hour of suspected sepsis or septic
shock. Crystalloids are the recommended fluid of choice for initial resuscitation and
subsequent intravascular volume replacement.
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Rationale. Sepsis is associated with vasodilation, capillary leakage, and decreased
circulating blood volume. This can lead to impaired tissue perfusion and organ
disfunction. The goal of fluid resuscitation in sepsis and septic shock is to restore
intravascular volume, increase oxygen delivery, and reverse organ dysfunction.
Resuscitation with initial fluid bolus requires evaluating the benefits and risks of fluid
administration based on the patient’s assessed volume status. For example, a patient with
heart failure may be considered fluid overload and the administration of fluids may
worsen this condition. However, the heart failure patient can die from sepsis if not
adequately treated whereas the fluid overload can be reversed.
Standard: 100%. An initial fluid administration bolus of 30 ml/kg crystalloid for
hypotension or a lactate of > 4 mmol/L within an hour of suspected sepsis or septic
shock.
6: Early Initiation of Inotropes. Placement of an arterial catheter as soon as
practical is recommended for patients requiring vasopressors
Rationale. Vasopressors and inotropes restore oxygen delivery to tissues by
increasing mean arterial pressure (MAP) and cardiac output. The practitioner must
consider the administration of vasopressors for hypotension that does not respond to fluid
bolus to maintain a MAP of 65 mm/Hg or greater. The drugs of choice include
Norepinephrine as the first choice for vasopressor, but indicated only in selected patients
(e.g., patients with low risk of tachyarrhythmias and absolute or relative Bradycardia).
Vasopressin (up to 0.03U/min) or Epinephrine to raise the MAP to target is suggested.
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Adding Vasopressin (up to 0.03U/min) to decrease Norepinephrine dosage and
Dopamine as an alternative vasopressor agent to Norepinephrine.
Standard: 100%. The medical provider must consider the administration of
vasopressors for hypotension that does not respond to fluid bolus to maintain a MAP of
65 mm/Hg or greater.
Expert Panel Review of the Clinical Practice Guideline
An expert panel was convened to assess the CPG using the criteria in the AGREE
II tool. The panel consisted of an ED medical director, an ED Director of Nursing, an ED
nurse manager, and an ED staff nurse. The AGREE II tool includes criteria to assess the
quality of a guideline's development process by six domains which include: scope and
purpose, stakeholder involvement, the rigor of development, clarity, and presentation,
application, editorial independence; Each domain of the Agree II tool includes items
numbered from 1 to 7, with each domain having a score calculated; an overall score is
then calculated by summing all the domains (see Table 3). Also, each evaluator selected
one of two overall guideline assessment choices: "lowest possible quality” or “highest
possible quality," with answers "Yes," "Yes, with modification," or "No."
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Table 3
AGREE Domains
AGREE II Tool Domains

Description

1. Scope and purpose

Project question and CPG aligns with the
Picker domains of patient centered care.

2. Stakeholder involvement

Four expert panelists involved in review.

3. Rigor of development

Best practices, current guidelines and evidence
used in development.

4. Clarity of presentation

CPG, and resources were clear and supported
with evidence.

5. Applicability

CPG and resources can be applied in a variety
of settings.

6. Editorial Independence

Each panelist completed an individual review
and presented individual comments.

I performed an analysis of the AGREE tool answers and scores completed by the
four evaluators according to the six domains of the AGREE II tool (see Table 4). The
Sepsis Clinical Guidelines scored highest in the domain of the guideline's scope and
purpose and clarity and presentation. All four evaluators gave the highest score for the
specific recommendations with clarity and the key recommendations as easily
identifiable. The stakeholder involvement and domain and editorial were having the
lowest scores. The evaluators gave high scores on the overall guideline assessment and
100% recommended the guideline for use (see Table 5). Three recommended without
modification; one evaluator scored recommended the guideline with modifications for
use in the ED, however, the modifications were not specified. All evaluators scored
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inclusion of patient stakeholders at the lowest level; however, this was to be expected as
this project was guided by the Rosswurm and Larrabee model of evidence-based practice
development Stages 1 through 4. In this model, stakeholders are part of the
implementation phase in Stages 5 and 6.
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Table 4
AGREE II Score Sheet
Domain
Scope and purpose

Item
1.

The overall objective(s) of the guideline is (are) specifically described.

Domain
average
21/21
100%

Stakeholder
involvement

Rigor of development

2.

The health question(s) covered by the guideline is (are) specifically described.

3.

The population patients, public, etc.) to whom the guideline is meant to apply is
specifically described.

4.

The guideline development group includes individuals from all the relevant professional
groups.

5.

The views and preferences of the target population (patients, public, etc.) have been
sought.

6.

The target users of the guideline are clearly defined.

7.

Systematic methods were used to search for evidence.

8.5/21
40%

50.25/56
90%

Clarity of presentation

8.

The criteria for selecting the evidence are clearly described.

9.

The strengths and limitations of the body of evidence are clearly described.

10.

The methods for formulating the recommendations are clearly described.

11.

The health benefits, side effects and risks have been considered in formulating the
recommendations.

12.

There is an explicit link between the recommendations and the supporting evidence.

13.

The guideline has been externally reviewed by experts prior to its publication.

14.

A procedure for updating the guideline is provided.

15.

The recommendations are specific and unambiguous.

20/21
95%

Applicability

16.

The different options for management of the condition or health issue are clearly
presented.

17.

Key recommendations are easily identifiable.

18.

The guideline describes facilitators and barriers to its application.

23/28
82%

Editorial independence

19.

The guideline provides advice and/or tools on how the recommendations can be put into
practice.

20.

The potential resource implications of applying the recommendations have been
considered.

21.

The guideline presents monitoring and/ or auditing criteria.

22.

The views of the funding body have not influenced the content of the guideline.

8/14
57%

23.

Competing interests of guideline development group members have been recorded and
addressed.
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Table 5
Overall Assessment
Overall Guideline
Assessment

1.

Rate the overall quality of this guideline.
1

2

3

4

5

6

4

Panel Rating

Overall Guideline
Assessment

2.

I would recommend this guideline for use.

7

Yes
3

Yes, with modifications
1

No
0

Contribution of the Doctoral Project Team
The team consisted of an ED medical director, ED director of nursing, ED nurse
manager, and ED staff nurse. This expert panel assessed the CPG using the AGREE tool
criteria. The guideline was recommended for use by the expert panel for nurses to review
either on their smart phones or internet-based learning-based management system
available in the ED (Healthstream).
Strengths and Limitations of the Project
There are strengths and limitations to this DNP doctoral project. This project's
main strength is its significance to the intended target audience, which are patients
presenting to the ED with suspected sepsis and registered nurses who need to identify
these patients so that early treatment can begin. The registered nurses' have a pivotal role
in identifying septic patients; having resources for guidance will reinforce the nurses'
knowledge and use of the evidence-based sepsis CPG to improve patient outcomes.
Using evidence-based sepsis guidelines within the project institution will be integrated
into the merging hospitals to provide care in a widening area and throughout the
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organizations. The project is limited by its inability to include patient stakeholders in the
process of development.

47
Section 5: Dissemination Plan
This project was the development of a CPG for use in the ED with input from an
expert advisory panel using the AGREE II criteria. The clinical guideline offers a sepsis
screening for clinicians in the ED in identify sepsis early to improve early targeted
treatment, thus improving sepsis patient outcomes for patients in the surrounding
community. The goal is to improve the early identification of sepsis symptoms and
prompt interventions to optimize sepsis care and improve the quality of life of individuals
in the community receiving sepsis care from the ED. Adequate evidence-based
intervention is crucial to patients’ survival; therefore, all clinicians providing care to the
institution patients need to be educated and aware of the morbidity and mortality of sepsis
and their role in improving the outcomes for these patients.
Dissemination of evidence-based practices can provide needed resources to assist
clinicians in providing the sepsis management care that is needed. Dissemination is a
vital factor of the quality improvement cycle by integrating the best available evidence
into standard practice. Dissemination of the project interventions of improving early
identification of sepsis symptoms of patients arriving in the ED can improve nursing
practices. I plan to share the quality improvement intervention with the project site’s ED.
This may encourage improvement in the EPIC triage prompts.
Analysis of Self
The lesson I learned in conducting this project is that organizational leadership
must be knowledgeable about evidence-based guidelines. I also learned that the
responsibility of an effective project leader involves conducting proper research when
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proposing change. This is done by using current evidence-based knowledge to guide
practice strategies and highlight quality improvement based on proven evidence. As I
learned, implementing a quality improvement strategy or project necessitates bridging the
gap between current practice and evidence-based practice by identifying the barriers and
facilitators of change. Clinical experience with the various nursing leaders empowers me
to develop evidence-based quality improvement projects/interventions within the
constraints of time and the institution's resources. This lesson learned from this project is
the meaning and importance of interprofessional collaboration, particularly about use of a
CPG for early recognition of sepsis in the ED, which will ultimately improve nursing
practice and patient outcomes.
Summary
In this project, I developed a CPG, informed by Rosswurm and Larrabee’s
evidence-based practice model and a literature search for use in the ED with input from
an expert advisory panel using the AGREE II criteria. Panel members unanimously
recommended the use of the guideline. In making sepsis screening a routine practice
informed by a clinical guideline, nurses can maximize outcomes of this population and
increase the SEP-1 scores.
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Appendix A: Sepsis Bundles
I created this table based on information in Rhodes et al. (2017).
3-hour and 6-hour sepsis bundle
3-hour bundle
Measure serum lactate.
Obtain blood cultures prior to antibiotic
administration.
Administer broad-spectrum antibiotics
within 3 hours from time of
presentation.
Administer 30ml/kg crystalloid for
hypotension or lactate ≥ 4mmol/L.
6-hour bundle
Apply vasopressors for hypotension not
responding to initial fluid resuscitation
to maintain mean arterial pressure
(MAP) ≥ 65mm Hg.
In the event of persistent hypotension
despite fluid resuscitation and/or lactate
> 4mmol/L.
Measure central venous pressure
(CVP).
Measure central venous oxygen
saturation (ScvO2) of ≥70%.
Remeasure lactate if initial lactate was
elevated.

2018 upgraded 1-hour bundle
Measure lactate level. Re-measure if
initial lactate is > 2mmol/L (weak
recommendation, low quality of
evidence).
Obtain blood cultures prior to
administration of antibiotics (best
practice statement).
Administer broad-spectrum
antibiotics (strong recommendation,
moderate quality of evidence).
Rapidly administer 30ml/kg
crystalloid for hypotension or lactate
≥ 4mmol/L (strong recommendation,
low quality of evidence).
Apply vasopressors if patient is
hypotensive during or after fluid
resuscitation to maintain MAP ≥
65mm Hg (strong recommendation,
moderate quality of evidence).

Appendix B: Table of Evidence
Author (Year)
Torsvik et al.
(2016)

Gyang et al. (2015)

Mattison et al.
(2016)

Research
design/Setting
Pre-postintervention
Emergency
Department

Medical record
review
Intermediate
Care Unit

Medical record
review
Oncology

Sample
881 patients

2143 screening
tests were
completed in 245
patients (169
surgical, 76
medical). ICD-9
codes confirmed
sepsis incidence
was 9%. Of the
39 patients who
screened
positive, 51%
were positive for
sepsis, and 49%
screened positive
for severe sepsis.
672 patients

Method

Findings that answer the question

Limitations

Pre- and post-intervention
study in one emergency and
community hospital within
the Mid-Norway Sepsis Study
catchment area. All patients
with confirmed bloodstream
infection were
registered on a
continuous
basis from 1994.
Retrospective
Analysis of
Completed
Screening
Forms

This research reported that early sepsis
recognition by ward nurses might have
reduced the progression of disease and
improved survival for patients in hospital
with sepsis.

One of the study’s has
important limitations such
as the use of a historical
pre-intervention group,
which does not ensure
comparison between pre-&
post
intervention and postintervention groups. .

Retrospective analysis was
performed at a specialist
oncology hospital in the
Northwest of England

During the study period, 697 patients
with suspected sepsis post chemotherapy
were included in the study. Six hundred
seventy-two (96.4 %) patients received
their first dose of intravenous antibiotics
within 60 min of presentation to the
institution. Of this group, 323 (48.1 %)
were administered antibiotics within 15
min of arrival. Of the 25 (3.6 %) patients
who did not receive antibiotics within 1
h, root cause analysis revealed the reason
in 23 (92 %) patients was an inability to
ascertain intravenous access.

The researchers demonstrated that a
simple screening tool for sepsis utilized
as part of nursing assessment may be a
useful to identify early sepsis in both
medical and surgical patients in an
intermediate care unit setting.

Level of evidence

III

III
Limitations are that the
study was conducted in
one unit.

The study is limited
because it was performed
in a specialist tertiary
oncology unit not an
emergency department

IV
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Author (Year)

Research
design/Setting

Sample

Method

postintervention
Emergency
Department

314
patients’ medical
Records

Descriptive
analysis

Rhodes et al. (2016)

Expert Opinion

Assess the
quality of 2012
SSC guidelines

Nishida et al.
(2018)

Expert Opinion

Rusconi et al.
(2015)

Systemic review
and metaanalysis based
on EGDT to
reduce mortality
with in severe
sepsis and septic
shock.

Adult patients
with confirmed
or suspected
sepsis or septic
shock.
Data from all
trials were
combined and
analyzed using a
random effects
model.

The panel were group
according to the following
areas:
hemodynamics, infection,
adjunctive therapies,
metabolic, and ventilation.
Population, intervention,
comparison, and outcomes
(PICO) questions were
reviewed and updated as
needed, and the generation of
evidence profiles
Meta-analyses for 29
clinical sepsis questions
and three large scales RCTs

Hayden et al.
(2016)

Medical record
review
Emergency
Department

238 patients’
charts were
analyzed in the
study

Relevant primary studies
were identified by searching
the MEDLINE and EMBASE
databases and the Cochrane
Central Register of Controlled
Clinical Trials to identify
randomized controlled trials
assessing the effectiveness of
EGDT for sepsis.
Retrospective data
comparison between the preand post-intervention group

Nurse-led protocols can be used as an
effective, safe method in achieving early
intervention with antibiotic
for patients with suspected febrile
neutropenia. (sepsis)
The study established a statistically
significant 230-minute reduction in time
to antibiotics post implementation of the
guidelines.
The sepsis guidelines improved early
assessment, recognition and management
of patients presenting with sepsis in one
tertiary referral emergency department.
The Surviving Sepsis Guideline panel
provided 93 statements on early
management and resuscitation of patients
with sepsis or septic shock. Overall, 32
were strong recommendations, 39 were
weak recommendations, and 18 were
best-practice statements. No
recommendation was provided for four
questions.

Limitations

Level of evidence

The study was conducted
in one urban Australian
tertiary referral ED, and
the results may not
represent other EDs or
those in different
geographical settings.

III

One in person meeting
other by teleconference.

V

The committee developed clinical
practice guidelines for the Japanese
healthcare clinicians

None noted

V

The study did not permit a definitive
conclusion of the utility of EGDT in
severe sepsis and septic shock due to.
variation in study
outcomes.

None noted

I

The investigators concluded that the use
of an EHR-based triage sepsis alert and
SWAT protocol led to a major reduction

Fewer charts were
analyzed in the pre
intervention group

IV

60

Romero et al.
(2017)

Findings that answer the question

Author (Year)

Research
design/Setting

Medical record
review
Emergency
Department

Leisman, (2019)

Medical record
review
Emergency
Department and
ICU

Oliver (2018)

Medical record
review
Emergency
Department

Patocka et al.
(2014)

Medical record
review
Emergency
Department

with 108 charts
in the pre-SWAT
group, and 130
charts in the
post-SWAT
group.
urban, teaching
ED
Study conducted
in a rural ED

Done in nine
hospitals over
two years.
To measure the
prevalence of
hospitalpresenting sepsis
(HPS) versus ED
presenting sepsis
(EDPS) patient
cases and
outcomes,
presenting
symptoms, and
patient outcomes
ED patients 18
years and older
with suspected
infection, and
two or more
systemic
response
185 patients with
severe sepsis or
septic shock in
the pre-triage
tool group and

Method

Findings that answer the question

Limitations

Level of evidence

in the time to intravenous fluids and time
to antibiotics

Analysis of a chart review
using a pre- and postscreening tool

The use of a screening tool led to a
decrease in door to antibiotic time

Analysis of the hospital
Sepsis Database, a
prospectively, of a
consecutive-sample cohort of
all “severe sepsis” and septic
shock patients treated at nine
tertiary and community
hospitals

The investigators found that hospitalpresenting sepsis (HPS) patients had
higher comorbidity and clinical
presentations and had more significant
mortality, LOS, and ICU utilization than
emergency department-presenting sepsis
(EDPS).
The EDPS patients received antibiotics
and fluids 1.62- 82 times more often than
HPS patients.

Pre and post interventional
screening tool analysis

The analysis showed a decreased in door
to antibiotic timing.
The study data did not conclude there
was a decreased in door to diagnosis,
door to lactate measurement or increased
in blood culture obtained before
antibiotic administration.
The implementing of the triage
assessment tool result in decreased time
to antibiotics by 21%. Sixty-four percent
of the patients who qualified for the

To determine the effect of a
triage screening tool on time
to antibiotics in patients with
severe sepsis or septic shock
presenting to the ED.

There were two
limitations.
a) the study was conducted
in a single ED.
b) the study was
conducted over a short
time of three.
months
The study did not
differentiate between HPS
patients admitted for
noninfectious reasons and
who became septic versus
non-septic patients
admitted for an infection
who then became septic
from that infection.

IV

IV

The study was conducted
in one hospital, and had a
short time applying
the screening tools.

IV

Conducted at one site

IV

61

Freund et al. (2017)

Sample

Author (Year)

Research
design/Setting

Sample
170 patients in
the post-triage
tool group

Method

Findings that answer the question

Limitations

Level of evidence

study were appropriately identified and
triaged post implementation
Although there was moderate adherence
(64%), the implementing of a sepsis
screening tool at triage have decreased
the time from triage to antibiotic
administration in patients presenting with
suspected severe sepsis or septic shock

62

